News

Cancer treatment–induced cardiotoxicity greatly underappreciated

Posted on: 10/11/2014 - 17:38

LAS VEGAS – When it comes to discussing the cardiotoxicity of cancer pharmacotherapies, it often seems that oncologists and cardiologists are on different planets. “You will see wildly different...

Field of Interest: Oncology

Type: News Item

Drug combination successful in hepatitis C plus HIV

Posted on: 10/11/2014 - 16:46

BOSTON – Treating hepatitis C with a combination of ledipasvir and sofosbuvir produced a sustained virologic response in 49 of 50 patients coinfected with genotype 1 hepatitis C and HIV...

Field of Interest: Gastroentero...

Type: News Item

Monitoring current threats, week 45/2014: ECDC Communicable Disease Threats Report10 Nov 2014

Posted on: 10/11/2014 - 16:08

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. -- Delivered by Feed43 service

Field of Interest: Infectious diseases

Type: News Item

Sofosbuvir-containing regimens dominate hepatitis C treatment

Posted on: 10/11/2014 - 15:49

BOSTON – Since their approval in late 2013, the direct-acting antiviral agents sofosbuvir and simeprevir have taken over treatment of hepatitis C with real-world success that approximates clinical...

Field of Interest: Gastroentero...

Type: News Item

Oral curcumin shown effective in psoriasis

Posted on: 10/11/2014 - 15:35

AMSTERDAM – Oral curcumin proved safe and effective as adjunctive therapy in patients on topical corticosteroids for mild to moderate psoriasis vulgaris in a 12-week, randomized, placebo-controlled...

Field of Interest: Dermatology

Type: News Item

Achieving sustained response key to successful HCV treatment

Posted on: 10/11/2014 - 14:05

BOSTON – Risks for mortality, hepatocellular carcinoma, and liver transplantations were significantly lower in patients with hepatitis C who achieved a sustained virologic response after treatment,...

Field of Interest: Gastroentero...

Type: News Item

ABT-450 combo achieves high SVR12 in hepatitis C

Posted on: 10/11/2014 - 00:00

FROM THE LIVER MEETING 2014A combined formula of ABT-450 with ritonavir, ombitasvir, and dasabuvir, given with ribavirin, yielded high rates of sustained viral response at 12 weeks among...

Field of Interest: Gastroentero...

Type: News Item

Viral suppression of HCV yielded improvements in neural health

Posted on: 10/11/2014 - 00:00

Viral suppression of hepatitis C virus–infected patients improved neural health as measured by magnetic resonance spectroscopy, according to findings from a new study. Treatment led to an increase...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir plus GS-5816 yielded high SVR rates in genotype 3 HCV patients

Posted on: 10/11/2014 - 00:00

Sofosbuvir plus GS-5816 yielded high SVR rates in genotype 3 HCV patientsvitalsKey clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR rates among...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir/ledipasvir improved patient-reported outcomes in HCV

Posted on: 10/11/2014 - 00:00

BOSTON - A hepatitis C treatment regimen of sofosbuvir and ledipasvir without ribavirin is associated with significant improvement in patient-reported outcomes, new research suggests.<br...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters